Active Ingredient(s): Carbidopa, Levodopa & Entacapone
Dosage: 50 mg / 200 mg / 200 mg
Form & Pack Size: 30 F.C. Tablets
Indication: Treatment of Parkinson’s disease
Parkless 50/200/200 mg delivers high-strength triple dopaminergic therapy for comprehensive control of advanced Parkinson’s disease. It maximizes levodopa bioavailability to ensure sustained motor stability and flexibility. Manufactured to world-class pharmaceutical standards to support patients every step of the way.
Committed to advancing global healthcare through the development, manufacturing, and distribution of high-quality pharmaceutical formulations.
© 2026 Zein Pharma. All rights reserved.
Reviews
There are no reviews yet.